retatrutide type 2 diabetes trial 2024 This data from Phase 3 clinical trials for was announced yesterday at @amdiabetesassn #ADA2026 ✓ We are fortunate to be living in a time where there multiple medications which safely reduce New clinical trial results show

Theyll provide better and safer guidelines regarding Semaglutide administration and dosage

J., Gotz, A., Tschop, M

We may not want to amplify signals your body already uses, at least long term

GLP-1 agonist weight loss medications like Wegovy and Saxenda have a high probability of causing thyroid cancer based on available evidence These medications were originally designed for diabetes and then repurposed for weight loss, which means the long-term thyroid safety data is still limited The potential benefits of GLP-1 agonists for weight loss must be carefully weighed against the significant risk of developing thyroid cancer If you're considering these medications, have a detailed conversation with your doctor about your personal thyroid cancer risk versus the weight loss benefits Do the most popular weight loss medications of our time like Wegovy and Saxenda cause thyroid cancer

Batch certificates are available for every unit produced

Room temperature solution is more comfortable than cold solution, so let the syringe warm in your hand for 30 seconds after drawing the dose (but do not leave the vial out of the fridge)